CCKBR and cancer: Minigastrin analogues have been extensively explored as potential tumour-targeting vectors for CCK2R-positive cancer cells and a screening test resulted in the truncated DOTA-conjugated octapeptide MG11 as a promising candidate with a high receptor affinity but poor plasma stability [111].